Lei Ma
Guangzhou Municipal And Guangdong Provincial Key Laboratory Of Molecular Target & Clinical Pharmacology, The NMPA And State Key Laboratory Of Respiratory Disease
Guangzhou, 511436, China
Guangzhou, 511436, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A unified cobalt-electrocatalytic platform for enantio- and stereo-selective C-H and C-F functionalization of gem-difluoromethylene allenes.
Journal: Chemical science
Published: March 18, 2026
Hexafluoroisopropanol-Mediated Cascade Cyclization for Construction of α‑Amino-γ-spirolactones.
Journal: JACS Au
Published: July 30, 2025
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation.
Journal: Metabolism: clinical and experimental
Published: September 30, 2024
Access to N-α-deuterated amino acids and DNA conjugates via Ca(II)-HFIP-mediated reductive deutero-amination of α-oxo-carbonyl compounds.
Journal: Nature communications
Published: August 20, 2024
Identification of Novel PPARγ Partial Agonists Based on Virtual Screening Strategy: In Silico and In Vitro Experimental Validation.
Journal: Molecules (Basel, Switzerland)
Published: August 09, 2024
Structure-based screening, optimization and biological evaluation of novel chrysin-based derivatives as selective PPARγ modulators for the treatment of T2DM and hepatic steatosis.
Journal: European journal of medicinal chemistry
Published: May 27, 2024
Raloxifene-driven benzothiophene derivatives: Discovery, structural refinement, and biological evaluation as potent PPARγ modulators based on drug repurposing.
Journal: European journal of medicinal chemistry
Published: January 18, 2024
Structure-based screening and biological validation of the anti-thrombotic drug-dicoumarol as a novel and potent PPARγ-modulating ligand.
Journal: Bioorganic chemistry
Published: August 04, 2022
Identification of a novel PPARγ modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 04, 2022
Correction to: CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
Journal: Cell death & disease
Published: March 03, 2022
Application of recombinase polymerase amplification method for rapid detection of infectious laryngotracheitis virus.
Journal: Molecular and cellular probes
Published: May 21, 2020
Identification and structural insight of an effective PPARγ modulator with improved therapeutic index for anti-diabetic drug discovery.
Journal: Chemical science
Published: October 31, 2019
Last Updated: 09/26/2026